Cathepsin B and its endogenous inhibitors: the role in tumor malignancy

Spyratos F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, Hacene K, Desplaces A, Rochefort H: An important marker predicting metastasis in primary breast cancer. Lancet (ii): 1115–1118, 1989 Tandon A, Clark G, Chamness G, Chirgwin J, McGuire WL: Cathepsin D and prognosis in breast cancer. N Engl J Med 322: 297–302, 1990 Pietras RJ, Szego CM: Cathepsin D in breast cancer (Letter to editor). N Engl J Med 322: 1673–1674, 1990 Recklies AD, Poole AR: Proteolytic mechanisms of tissue destruction in tumor growth and metastasis. In: Weiss L, Gilbert HA (eds) Liver metastasis. GK Hall, Boston, 1982, pp 77–95 Sloane BF, Honn KV: Cysteine proteinases and metastasis. Cancer Metastasis Rev 3: 249–263, 1984 Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV: Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp Cell Biol 55: 209–224, 1987 Recklies AD: Biochemical aspects of cellular migration and invasion. Biorheology 23: 93–103, 1987 Sloane BF: Cathepsin B and cystatins: evidence for a role in cancer progression. Semin Cancer Biol 1: 137–152, 1990 Sloane BF, Krepela E, Lah TT: Regulation of lysosomal proteinases in neoplasia. In: Pretlow TG, Pretlow TP (eds) Aspects of the biochemistry and molecular biology of tumors. Academic Press, NY, in press Collela R, Denhardt D: Anti-cancer activities of naturally occurring cysteine proteinase inhibitors. In: Troll W, Kennedy A (eds) Proteinase inhibitors as cancer chemopreventive agents. Plenum Press, New York, in press. Willstatter R, Bamann E: Uber die proteasen der magenschleimhaut. Erste abhandlung uber die enzyme der leukocyten. Hoppe-Seylers Z Physiol Chem 180: 127–143, 1929 Kornfeld S, Mellman I: The biogenesis of lysosomes. Annu Rev Cell Biol 5: 483–525, 1989 Barrett AJ, Kirschke H: Cathepsin B, cathepsin H, cathepsin L. Meth in Enzymol 80: 535–561, 1981 Chan SJ, San Segundo B, McCormick MB, Steiner DF: Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proc Natl Acad Sci USA 83: 7721–7725, 1986 Hanewinkel H, Glossl J, Kresse H: Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. J Biol Chem 262: 12351–12355, 1987 Kominami E, Tsukahara T, Hara K, Katunuma N: Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages. FEBS Lett 231: 225–228, 1988 Hara K, Kominami E, Katunuma N: Effect of proteinase inhibitors on intracellular processing of cathepsin B, H and L in rat macrophages. FEBS Lett 231: 229–231, 1988 Nishimura Y, Kawabata T, Kato K: Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch Biochem Biophys 261: 64–71, 1988 Takahashi T, Dehdarani AH, Yonezawa S, Tang J: Porcine spleen cathepsin B is an exopeptidase. J Biol Chem 261: 9375–9381, 1986 Mason RW: Interaction of lysosomal cysteine proteinases with α2-macroglobulin: conclusive evidence for the endopeptidase activities of cathepsins B and H. Arch Biochem Biophys 273: 367–374, 1989 Rozhin J, Robinson D, Stevens MA, Lah TT, Honn KV, Ryan RE, Sloane BF: Properties of a plasma membraneassociated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. Cancer Res 47: 6620–6628, 1987 Kirschke H, Locnikar P, Turk V: Species variations amongst lysosomal cysteine proteinases. FEBS Letts 174: 123–127, 1984 Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CJ, Tamai M, Hanada K: L-trans-epoxysuccinylleucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 201: 189–198, 1982 Green GDJ, Shaw E: Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. J Biol Chem 256: 1923–1928, 1981 Crawford C, Mason RW, Wikstrom P, Shaw E: The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B. Biochem J 253: 751–758, 1988 Kirschke H, Shaw E: Rapid inactivation of cathepsin L by Z-Phe-PheCHN2 and Z-Phe-AlaCHN2. Biochem Biophys Res Commun 101: 454–458, 1981 Shaw E: Peptidyl sulfonium salts. J Biol Chem 263: 2768–2772, 1988 Rich DH: Inhibitors of cysteine proteinases. In: Barrett AJ, Salvesen G (eds) Proteinase inhibitors. Elsevier, Amsterdam, 1986, pp 153–178 Demuth HU: Recent developments in inhibiting cysteine and serine proteases. J Enzym Inhib 3: 249–278, 1990 Smith RA, Coles PJ, Spencer RW, Copp LJ, Jones CS, Krantz A: Peptidyl O-acyl hydroxamates: potent new inactivators of cathepsin B. Biochem Biophys Res Commun 155: 1201–1206, 1988 Willenbrock F, Brocklehurst K: A general framework of cysteine-proteinase mechanism deduced from studies on enzymes with structurally different analogous catalytic-site residues Asp-158 and-161 (papain and actinidin), Gly-196 (cathepsin B) and Asn-165 (cathepsin H). Biochem J 227: 521–528, 1985 Lah TT, Buck MR, Honn KV, Crissman JD, Rao NC, Liotta LA, Sloane BF: Degradation of laminin by human tumor cathepsin B. Clin Exp Metastasis 7: 461–468, 1989 Mort JS, Recklies AD: Interrelationship of active and latent secreted human cathepsin B precursors. Biochem J 233: 57–63, 1986 Sloane BF, Dunn JR, Honn KV: Lysosomal cathepsin B: correlation with metastatic potential. Science 212: 1151–1153, 1981 Sloane BF, Honn KV, Sadler JG, Turner WA, Kimpson JJ, Taylor JD: Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res 42: 980–986, 1982 Ryan RE, Crissman JD, Honn KV, Sloane BF: Cathepsin B-like activity in viable tumor cells isolated from rodent tumors. Cancer Res 45: 3636–3641, 1985 Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV: Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci USA 83: 2483–2487, 1986 Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV: Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp Cell Biol 55: 209–224, 1987 Moin K, Rozhin J, McKernan TB, Sanders VJ, Fong D, Honn KV, Sloane BF: Enhanced levels of cathepsin B mRNA in murine tumors. FEBS Lett 244: 61–64, 1989 Keren Z, LeGrue SJ: Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction. Cancer Res 48: 1416–1421, 1988 Qian F, Bajkowski AS, Steiner DF, Chan SJ, Frankfater A: Expression of five cathepsins in murine melanomas of varving [sic] metastatic potential and normal tissues. Cancer Res 49: 4870–4875, 1989 Recklies AD, Poole AR, Mort JS: A cysteine proteinase secreted from human breast tumors is immunologically related to cathepsin B. Biochem J 207: 633–636, 1982 Mort JS, Leduc M, Recklies A: A latent thiol proteinase from ascitic fluid of patients with neoplasia. Biochim Biophys Acta 662: 173–180, 1981 Lah TT, Clifford JL, Helmer KM, Day NA, Moin K, Honn KV, Crissman JD, Sloane BF: Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim Biophys Acta 993: 63–73, 1989 Rozhin J, Gomez AP, Ziegler GH, Nelson KK, Chang YS, Fong D, Onoda JM, Honn KV, Sloane BF: Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res, 50: 6278–6284, 1990 Koppel P, Baici A, Keist R, Matzku S, Keller R: Cathepsin B like proteinase as a marker for tumor cell variants. Exp Cell Biol 52: 293–299, 1984 Recklies AD, Tiltman KJ, Stoker TAM, Poole AR: Secretion of proteinases from malignant and non-malignant human breast tissue. Cancer Res 40: 550–556, 1980 Murnane MJ: Cathepsin B expression in human colorectal carcinoma. Cancer Res, in press. Bernhard HP, Darlington, Ruddle FH: Evidence of liver phenotypes in cultured mouse hepatoma cells: synthesis and secretion of serum albumin. Dev Biol 35: 83–96, 1973 San Segundo B, Chan SJ, Steiner DF: Differences in cathepsin B mRNA levels in rat tissue suggest specialized functions. FEBS Lett 201: 251–256, 1986 Fong D, Calhoun DH, Hsieh W-T, Lee B, Wells RD: Isolation of a cDNA clone for the human lysosomal proteinase cathepsin B. Proc Natl Acad Sci USA 83: 2909–2913, 1986 Qian F, Chan SJ, Bajkowski AS, Steiner DF, Frankfater A: Characterization of three cathepsin B mRNA transcripts in murine B16a melanoma. FASEB J 4: A1817, 1990 Azuma T, Pals G, Mohandas TK, Couvreur JM, Taggart RT: Human gastric cathepsin E: predicted sequence, localization to chromosome 1 and sequence homology with other aspartic proteinases. J Biol Chem 264: 16748–16753, 1989 Pagano M, Dalet-Fumeron V, Engler R: The glycosylation state of the precursors of the cathepsin B-like proteinase from human malignant ascitic fluid: Possible implication in the secretory pathway of these proenzymes. Cancer Lett 45: 13–19, 1989 Pagano M, Capony F, Rochefort H: La pro-cathepsine D peut activer in vitro la pro-cathepsine B sécrétée par les cancers ovariens. CR Acad Sci Paris 309: 7–12, 1989 Lowy DR, Willumsen BM: New clue to ras lipid glue. Nature 341: 384–385, 1989 Chi L, Zhu M, Marks N: High affinity binding of rat brain cathepsin B to purified rat/bovine cerebral mannose 6-phosphate receptors. Biol Chem Hoppe-Seyler 371 suppl: 259–264, 1990 vanDongen JM, Willensen R, Ginns EI, Sips HJ, Tager JM, Barranger JA, Reuser AJJ: The subcellular localization of soluble and membrane bound lysosomal enzymes in I-cell fibroblasts: a comparative immunocytochemical study. Eur J Cell Biol 39: 179–189, 1985 Cavanaugh PG, Sloane BF, Bajkowski AS, Gasic GJ, Gasic TB, Honn KV: Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clin Exp Metastasis 1: 297–307, 1983 Rozhin J, Wade RL, Honn KV, Sloane BF: Membrane-associated cathepsin L: a role in metastasis of melanomas. Biochem Biophys Res Commun 164: 556–561, 1989 Jensen HK, Ledet T: Proteolysis of arterial basement membrane containing different amounts of carbohydrates. Thromb Res 44: 47–53, 1986 Maciewicz RA, Wardale RJ, Etherington DJ, Paraskeva C: Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int J Cancer 43: 478–486, 1989 Ohsawa T, Higashi T, Tsuji T: The secretion of high molecular weight cathepsin B from cultured human liver cancers. Acta Med Okayama 43: 9–15, 1989 Goldberg DE, Gabel CA, Kornfeld S: Studies of the biosynthesis of the mannose 6-phosphate receptor in receptor-positive and-deficient cell lines. J Cell Biol 97: 1700–1706, 1983 Mainferme F, Wattiaux R, vonFigura K: Synthesis, transport and processing of cathepsin C in Morris hepatoma 7777 cells and rat hepatocytes. Eur J Biochem 153: 211–216, 1985 Prence EM, Dong J, Sahagian GG. Modulation of the transport of a lysosomal enzyme by PDGF. J Cell Biol 110: 319–326, 1990 Erdel M, Trefz G, Spiess E, Habermaas S, Spring H, Lah T, Ebert W: Localization of cathepsin B in two human lung cancer cell lines. J Histochem Cytochem (in press) Krepela E, Bartek J, Skalkova D: Cytochemical and biochemical evidence of cathepsin B in malignant, transformed and normal breast epithelial cells. J Cell Sci 87: 145–154, 1987 Barrett AJ: The cystatins: a new class of peptidase inhibitors. Trends Biochem Sci 12: 193–196, 1987 Muller-Esterl W, Iwanaga S, Nakanishi S: Kininogens revisited. Trends Biochem Sci 11: 336–339, 1986 Green GDJ, Kembhavi AA, Davies ME, Barrett AJ: Cystatin-like cysteine proteinase inhibitors from human liver. Biochem J 218: 939–946, 1984 Nicklin MJH, Barrett AJ: Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin. Biochem J 223: 245–253, 1984 Hawley-Nelson P, Roop DR, Cheng CK, Krieg TM, Yuspa SH: Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis. Mol Carcinogenesis 1: 202–211, 1988 Rinne A, Jarvinen M, Rasanen O, Hopsu-Havu VK: Acid and neutral cysteine proteinase inhibitor in normal uterine portio and in squamo-epithelial metaplasia, dysplasias and infiltrative carcinoma of the uterine portio. Exp Pathol 26: 67–70, 1984 Kyllonen AP, Jarvinen M, Hopsu-Havu VK, Dorn A, Rasanen O, Larmi T, Rinne A: The behaviour of small molecular cysteine proteinase inhibitors in lung cancers and in surrounding tissue. Acta Histochem 74: 109–113, 1984 Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A, Jensson O: A mutation in the cystatin C gene causes hereditary brain hemorrhage. Lancet 1988: 603–604, 1988 Liotta LA, Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin Cancer Biol 1: 99–106, 1990 Redhead S: Osteoclastic bone resorption: all hands to the proton pump. J NIH Res 2: 57–60, 1990 Baron R: Molecular mechanism of bone resorption by osteoclasts. Anat Rec 224: 317–324, 1989 Canalis E, McCarthy T, Centrella M: Growth factors and the regulation of bone remodeling. J Clin Invest 81: 277–281, 1988 Kornfeld S: Lysosomal enzyme targeting. Biochem Soc Trans 18: 367–374, 1990 Kornfeld S: Trafficking of lysosomal enzymes. FASEB J 1: 462–468, 1987 Roederer M, Bowser R, Murphy RF: Kinetics and temperature dependence of exposure of endocytosed material to proteolytic enzymes and low pH: evidence for a maturation model for the formation of lysosomes. J Cell Physiol 131: 200–209, 1987 Roederer M, Barry JR, Wilson RB, Murphy RF: Endosomes can undergo an ATP-dependent density increase in the absence of dense lysosomes. Eur J Cell Biol 51: 229–234, 1990 Silver IA, Murrills RJ, Etherington DJ: Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175: 266–276, 1988 Grossi IM, Hatfield JS, Fitzgerald LA, Newcombe M, Taylor JD, Honn KV: Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions. FASEB J 2: 2385–2395, 1988 Ghelsen KR, Argraves WS, Pierschbacher MD, Ruoslahti E: Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol 106: 925–930, 1988 Kramer RH, McDonald KA, Crowley E, Ramos DM, Damsky CH: Melanoma cell adhesion to basement membrane mediated by integrin-related complexes. Cancer Res 49: 393–402, 1989 Skudlarek MD, Swank RT: Turnover of two lysosomal enzymes in macrophages. J Biol Chem 256: 10137–10144, 1981 Reilly JJ, Mason RW, Chen P, Joseph LJ, Sukhatme VP, Yee R, Chapman HA: Synthesis and processing of cathepsin L, an elastase, by human alveolar macrophages. Biochem J 257: 493–498, 1989 Sloane BF, Ryan RE, Rozhin J, Lah TT, Crissman JD, Honn KV: Cathepsin B: A proteinase linked to metastasis? In: Tschesch H (ed) Proteinases in inflammation and tumor invasion. deGruyter, Berlin, 1986, pp 93–106 Achkar C, Gong Q, Frankfater A, Bajkowski AS: Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Molony murine sarcoma virus transformed BALB/3T3 fibroblasts. J Biol Chem 265: 13650–13654, 1990 Dong J, Prence EM, Sahagian GG: Mechanism for selective secretion of a lysosomal proteinase by transformed mouse fibroblasts. J Biol Chem 264: 7377–7383, 1989 Dong J, Sahagian GG: Basis for low affinity binding of a lysosomal cysteine protease to the cation-independent mannose 6-phosphate receptor. J Biol Chem 265: 4210–4217, 1990 Heuser J: Changes in lysosomal shape and distribution correlated with changes in cytoplasmic pH. J Cell Biol 108: 855–864, 1989 Krepela E, Vesely P, Chaloupkova A, Zicha D, Urbanec P, Rasnick D, Vicar J: Cathepsin B in cells of two rat sarcomas with different rates of spontaneous metastasis. Neoplasma 36: 529–540, 1989 Murphy RF: Processing of endocytosed material. Advan Cell Biol 2: 159–180, 1988 Baricos WH, Zhou Y, Mason RW, Barrett AJ: Human kidney cathepsins B and L. Biochem J 252: 301–304, 1988 Gingras MC, Jarolim L, Finch J, Bowden GT, Wright JA, Greenberg AH: Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts. Cancer Res 50: 4061–4066, 1990